1,460
Views
31
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: CENTRAL NERVOUS SYSTEM TUMOMRS

Validation of an established prognostic score after re-irradiation of recurrent glioma

, , , , , , & show all
Pages 422-426 | Received 14 Aug 2016, Accepted 20 Dec 2016, Published online: 11 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carsten Nieder, Johannes A. Langendijk, Matthias Guckenberger & Anca L. Grosu. (2018) Second re-irradiation: a narrative review of the available clinical data. Acta Oncologica 57:3, pages 305-310.
Read now

Articles from other publishers (30)

Raffaella De Pietro, Lucy Zaccaro, Francesco Marampon, Paolo Tini, Francesca De Felice & Giuseppe Minniti. (2023) The evolving role of reirradiation in the management of recurrent brain tumors. Journal of Neuro-Oncology.
Crossref
M. Maitre, T. Gupta, P. Maitre, A. Chatterjee, A. Dasgupta, A. Moiyadi, P. Shetty, S. Epari, A. Sahay, V. Patil, R. Krishnatry, G.J. Sastri & R. Jalali. (2022) High-dose salvage re-irradiation in recurrent/progressive adult diffuse gliomas: development of a novel prognostic scoring system. Cancer/Radiothérapie 26:8, pages 994-1001.
Crossref
Mateo Ziu, Sharad Goyal & Jeffrey J. Olson. (2021) Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of radiation therapy in the management of progressive and recurrent glioblastoma in adults. Journal of Neuro-Oncology 158:2, pages 255-264.
Crossref
Pierina Navarria, Federico Pessina, Elena Clerici, Luisa Bellu, Ciro Franzese, Andrea Franzini, Matteo Simonelli, Lorenzo Bello, Armando Santoro, Letterio Salvatore Politi, Giuseppe Roberto D'agostino, Alessandra Casarotti, Bethania Fernandes, Valter Torri & Marta Scorsetti. (2022) Re-irradiation for recurrent high grade glioma (HGG) patients: Results of a single arm prospective phase 2 study. Radiotherapy and Oncology 167, pages 89-96.
Crossref
Giuseppe Minniti, Maximilian Niyazi, Filippo Alongi, Piera Navarria & Claus Belka. (2021) Current status and recent advances in reirradiation of glioblastoma. Radiation Oncology 16:1.
Crossref
T. Gupta, M. Maitre, P. Maitre, J. S. Goda, R. Krishnatry, A. Chatterjee, A. Moiyadi, P. Shetty, S. Epari, A. Sahay, V. Patil & R. Jalali. (2021) High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?. Clinical and Translational Oncology 23:7, pages 1358-1367.
Crossref
Silvia Scoccianti, Marco Perna, Emanuela Olmetto, Camilla Delli Paoli, Francesca Terziani, Lucia Pia Ciccone, Beatrice Detti, Daniela Greto, Gabriele Simontacchi, Roberta Grassi, Erika Scoccimarro, Pierluigi Bonomo, Monica Mangoni, Isacco Desideri, Vanessa Di Cataldo, Marco Vernaleone, Marta Casati, Stefania Pallotta & Lorenzo Livi. (2021) Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery. Critical Reviews in Oncology/Hematology 157, pages 103184.
Crossref
V. R. Anjali, Supriya Mallick & Rony Benson. 2021. Evidence based practice in Neuro-oncology. Evidence based practice in Neuro-oncology 125 137 .
Helena C. W. Wahner, Malte Träger, Katja Bender, Leonille Schweizer, Julia Onken, Carolin Senger, Felix Ehret, Volker Budach & David Kaul. (2020) Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients. Radiation Oncology 15:1.
Crossref
Christoph Straube, Kerstin A. Kessel, Stefanie Antoni, Jens Gempt, Bernhard Meyer, Juergen Schlegel, Friederike Schmidt-Graf & Stephanie E. Combs. (2020) A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma. Radiation Oncology 15:1.
Crossref
Stephanie E. Combs, Claus Belka, Maximilian Niyazi, Stefanie Corradini, Steffi Pigorsch, Jan Wilkens, Anca L. Grosu, Matthias Guckenberger, Ute Ganswindt & Denise Bernhardt. (2020) First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments. Radiation Oncology 15:1.
Crossref
Anna Kirstein, Thomas E. Schmid & Stephanie E. Combs. (2020) The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme. Cancers 12:5, pages 1099.
Crossref
Kerstin A. Kessel & Stephanie E. Combs. (2019) Digital biomarkers: Importance of patient stratification for re-irradiation of glioma patients – Review of latest developments regarding scoring assessment. Physica Medica 67, pages 20-26.
Crossref
Christoph Straube, Kerstin A. Kessel, Claus Zimmer, Friederike Schmidt-Graf, Jürgen Schlegel, Jens Gempt, Bernhard Meyer & Stephanie E. Combs. (2019) A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital Biomarkers. Current Treatment Options in Oncology 20:10.
Crossref
Shahed N. Badiyan, Michael S. Rutenberg, Bradford S. Hoppe, Pranshu Mohindra, Gary Larson, William F. Hartsell, Henry Tsai, Jing Zeng, Ramesh Rengan, Erica Glass, Sanford Katz, Carlos Vargas, Steven J. Feigenberg & Charles B. SimoneIIII. (2019) Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies. Practical Radiation Oncology 9:4, pages 280-288.
Crossref
Christoph Straube, Stefanie Antoni, Jens Gempt, Claus Zimmer, Bernhard Meyer, Jürgen Schlegel, Friederike Schmidt-Graf & Stephanie E. Combs. (2019) Re-irradiation in elderly patients with glioblastoma: a single institution experience. Journal of Neuro-Oncology 142:2, pages 327-335.
Crossref
Il Han Kim. (2019) Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation. Radiation Oncology Journal 37:1, pages 1-12.
Crossref
Cathalijne C.B. Post, Miranda C.A. Kramer, Ernst J. Smid, Hiske L. van der Weide, Catharina E. Kleynen, Mart A.A.M. Heesters & Joost J.C. Verhoeff. (2019) Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score. Radiotherapy and Oncology 130, pages 156-163.
Crossref
Fabio Y. Moraes, Gustavo Nader Marta, Erin S. Murphy & John H. Suh. 2019. Oligodendroglioma. Oligodendroglioma 271 278 .
Sahas Narain, Ashwini Kini & Aparna Ramasubramanian. 2019. Ocular Oncology. Ocular Oncology 47 60 .
Jan C. Peeken, Tatyana Goldberg, Thomas Pyka, Michael Bernhofer, Benedikt Wiestler, Kerstin A. Kessel, Pouya D. Tafti, Fridtjof Nüsslin, Andreas E. Braun, Claus Zimmer, Burkhard Rost & Stephanie E. Combs. (2018) Combining multimodal imaging and treatment features improves machine learning‐based prognostic assessment in patients with glioblastoma multiforme. Cancer Medicine 8:1, pages 128-136.
Crossref
Seok-Joo Chun, Sung-Hye Park, Chul-Kee Park, Jin Wook Kim, Tae Min Kim, Seung Hong Choi, Soon-Tae Lee & Il Han Kim. (2018) Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups. Radiotherapy and Oncology 128:2, pages 254-259.
Crossref
Jan C. Peeken, Josefine Hesse, Bernhard Haller, Kerstin A. Kessel, Fridtjof Nüsslin & Stephanie E. Combs. (2018) Semantic imaging features predict disease progression and survival in glioblastoma multiforme patientsSemantische Bildeigenschaften prognostizieren Tumorprogression und Überleben von Patienten mit Glioblastoma multiforme. Strahlentherapie und Onkologie 194:6, pages 580-590.
Crossref
Stephanie E. Combs, Maximilian Niyazi, Sebastian Adeberg, Nina Bougatf, David Kaul, Daniel F. Fleischmann, Arne Gruen, Emmanouil Fokas, Claus M. Rödel, Franziska Eckert, Frank Paulsen, Oliver Oehlke, Anca‐Ligia Grosu, Annekatrin Seidlitz, Annika Lattermann, Mechthild Krause, Michael Baumann, Maja Guberina, Martin Stuschke, Volker Budach, Claus Belka, Jürgen Debus & Kerstin A. Kessel. (2018) Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group ( ROG ) of the German Cancer Consortium ( DKTK ) . Cancer Medicine 7:5, pages 1742-1749.
Crossref
Maximilian Niyazi, Sebastian Adeberg, David Kaul, Anne-Laure Boulesteix, Nina Bougatf, Daniel F. Fleischmann, Arne Grün, Anna Krämer, Claus Rödel, Franziska Eckert, Frank Paulsen, Kerstin A. Kessel, Stephanie E. Combs, Oliver Oehlke, Anca-Ligia Grosu, Annekatrin Seidlitz, Annika Lattermann, Mechthild Krause, Michael Baumann, Maja Guberina, Martin Stuschke, Volker Budach, Claus Belka & Jürgen Debus. (2018) Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis. Radiotherapy and Oncology 127:1, pages 121-127.
Crossref
A.L.K. Ho & R. Jena. (2018) Re-irradiation in the Brain: Primary Gliomas. Clinical Oncology 30:2, pages 124-136.
Crossref
Andra Valentina Krauze, Cord Peters, Jason Cheng, Holly Ning, Megan Mackey, Lindsay Rowe, Theresa Cooley-Zgela, Dee Dee Smart & Kevin Camphausen. (2017) Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system. Radiation Oncology 12:1.
Crossref
Sophia Scharl, Christoph Straube, Bernhard Meyer, Friederike Schmidt-Graf & Stephanie E. Combs. (2017) Kritische Betrachtung der Leitlinie der Europäischen Gesellschaft für Neuroonkologie (EANO) zur Diagnostik und Behandlung von adulten astrozytären und oligodendroglialen GliomenCritical consideration of the European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Strahlentherapie und Onkologie 193:11, pages 984-988.
Crossref
Christoph Straube, Greeshma Elpula, Jens Gempt, Julia Gerhardt, Stefanie Bette, Claus Zimmer, Friederike Schmidt-Graf, Bernhard Meyer & Stephanie E. Combs. (2017) Re-irradiation after gross total resection of recurrent glioblastomaRebestrahlung nach kompletter Resektion eines rezidivierten Glioblastoms. Strahlentherapie und Onkologie 193:11, pages 897-909.
Crossref
Kerstin A. Kessel, Josefine Hesse, Christoph Straube, Claus Zimmer, Friederike Schmidt-Graf, Jürgen Schlegel, Bernhard Meyer & Stephanie E. Combs. (2017) Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma. PLOS ONE 12:7, pages e0180457.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.